A PHARMARCEUTICAL COMPOSITION CAPABLE OF INHIBITING REPLICATION OF CORONAVIRUS

The present invention relates to a pharmaceutical composition capable of inhibiting replication of coronavirus in a subject upon administrating the composition in an effective amount to the subject, the composition comprising an extract acquired from a plant part of Boesenbergia sp. having Pandurati...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HONGENG, Suradej, TUCHINDA, Patoomratana, BORWORNPINYO, Suparerk, KANJANASIRIRAT, Phongthon, WONGTRAKOONGATE, Patompon, CHUTIPONGTANATE, Somchai, SUKSATU, Ampa, MANOPWISEDJAROEN, Suwimon, RANGKASENEE, Noppawan, CHAROENSUTTHIVARAKUL, Sitthivut, THITITHANYANONT, Arunee, CHABANG, Napason, MUNYOO, Bamroong
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a pharmaceutical composition capable of inhibiting replication of coronavirus in a subject upon administrating the composition in an effective amount to the subject, the composition comprising an extract acquired from a plant part of Boesenbergia sp. having Panduratin A and Pinostrobin in a molar ratio of 1:4 to 1:10. The composition may further comprise or incorporated with or being used along with an antiviral agent to achieve a synergistic effect against coronavirus.